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Mixed Viral-Bacterial Infections and 
Their Effects on Gut Microbiota and 
Clinical Illnesses in Children
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Asmaa A. Al thani1,3 & Hadi M. Yassine  1,3
Acute gastroenteritis remains a major cause of morbidity and mortality among young children 
worldwide. It accounts for approximately 1.34 million deaths annually in children younger than five 
years. Infection can be caused by viral, bacterial and/or parasitic microorganisms. Dysbiosis due to 
such infections could dramatically affect disease prognosis as well as development of chronic illness. 
The aim of this study was to analyze gut microbiome and clinical outcomes in young children suffering 
from viral or mixed viral-bacterial infection. We evaluated gut microbiota composition in children 
suffering from viral or mixed viral-bacterial infection with two major viruses rotavirus (RV) and norovirus 
(NoV) and two pathogenic bacteria [Enteroaggregative E. coli (EAEC), and Enteropathogenic E. coli 
(EPEC)]. We sequenced 16S ribosomal RNA (V4 region) genes using Illumina MiSeq in 70 hospitalized 
children suffering from gastroenteric infections plus nine healthy controls. The study summarized 
Operational Taxonomic Unit (OTU) abundances with the Bray-Curtis index and performed a non-
metric multidimensional scaling analysis to visualize microbiome similarities. We used a permutational 
multivariate analyses of variance to test the significance of group differences. We also analyzed the 
correlation between microbiome changes and clinical outcomes. Our data demonstrated a significant 
increase in the severity score in children with viral-bacterial mixed infections compared to those with 
virus infections alone. Statistical analysis by overall relative abundance denoted lesser proportions 
of Bacteroides in the infected children, whereas Bifidobacteriaceae richness was more prominent in 
the bacterial-viral mixed infections. Pairwise differences of gut microbiota were significantly higher in 
RV + EAEC (P = 0.009) and NoV + EAEC (P = 0.009) co-infections, compared to EPEC mixed infection 
with both, RV (P = 0.045) and NoV (P = 0.188). Shannon diversity index showed considerable more 
variation in microbiome diversity in children infected with RV cohort compared to NoV cohort. Our 
results highlight that richness of Bifidobacteriaceae, which acts as probiotics, increased with the 
severity of the viral-bacterial mixed infections. As expected, significant reduction of relative numbers 
of Bacteroides was characterized in both RV and NoV infections, with more reduction observed in co-
infection pathogenic E. coli. Although mixed infection with EAEC resulted in significant microbiota 
differences compared to viral infection only or mixed infection with EPEC, the clinical condition of the 
children were worsened with both pathogenic E.coli co-infections. Further, in comparison with RV 
cohort, augmented number of differential abundant pathogenic OTUs were peculiarly noticed only with 
NoV mixed infection.
The human gastrointestinal tract (GIT) is a reservoir of the largest community of commensals in the body, and 
hence, recent research has studied gut microbiome extensively1,2. Gut microflora plays a crucial role in health and 
disease through maintaining several physiological processes such as food digestion, immunity and metabolism3–6. 
Consequently, alteration of the structure and function of gut microflora has been linked to several human com-
plications including colonization of pathogenic bacteria, susceptibility to autoimmune disorders, obesity, and 
gastrointestinal disorders such as inflammatory bowel disease1,7–9.
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Healthy children gut microbiota is dynamic and undergoes rapid changes, which is affected by multiple fac-
tors including mode of birth delivery, aging process, diet, and use of antibiotics10. GIT microbiome in children 
is largely colonized by bacteria belonging to Bacteroidetes, Firmicutes and Proteobacteria phyla11. Facultative 
bacteria such as Escherichia coli (E. coli), Enterococcus, α-hemolytic Streptococci, and Staphylococcus species have 
been found to colonize the anaerobic GIT of infants during their first days after birth, followed by colonization 
of anaerobic bacteria including Bacteroides, Bifidobacterium, and Clostridium species, due to the presence of 
anaerobic conditions and human milk oligosaccharides12. Typically, the healthy gut microbiota is composed of 
only a minor proportion of Proteobacteria phylum, and thus, high abundance of these bacteria is often a sign of 
imbalanced microbiome13,14.
GIT is also a common site of infections in children younger than 5 years15. Acute gastroenteritis (AGE) leads 
to around 1.34 million deaths annually, or nearly 15% of all child fatalities16,17. Viral infections remain the leading 
cause of AGE in children, particularly noroviruses (NoV) and rotaviruses (RV)18. NoV are group of RNA viruses 
that are responsible for about one fifth of AGE cases globally19. Annually, these viruses lead to around 200 million 
cases in children less than 5 years old, and result in about 50,000 fatalities19,20. RV is also one of the main viral 
agents of AGE worldwide. Despite the availability of rotavirus vaccine (RVV), this virus is the most common 
cause of diarrhea related deaths in children, contributing to 215,000 deaths in young children every year, particu-
larly in low-income countries21,22.
Gut microflora plays a critical role in immune response and pathogenesis of GIT infection especially in young 
children, where GIT infections are major cause of morbidity and mortality. Accordingly, several studies have 
investigated the correlation between intestinal microbiota composition and immune response to RVV22–24. On 
the other hand, immune tolerance to gut microflora is an essential component of mucosal immunity25. Loss of 
this immune tolerance has been reported as a consequence GIT infection, where immune response to commen-
sals parallels the immune response to pathogenic microorganisms25. Virally-infected infant’s exhibit altered gut 
microbiota after infection, which may put them at higher risk of developing health complications26. More recently, 
it was reported that children with severe viral AGE, particularly patients infected with RV, have decreased intes-
tinal microbiota diversity compared to healthy controls24. The use of antibiotics following viral infections has 
also been linked to gut microbiota alteration in children25–27. Nonetheless, the current data concerning the con-
tribution of gut microbiota in the development, complications, and pathogenesis of AGE is still limited, which 
underscores the need for more investigations.
In this present study, we evaluated gut microbiota composition in children suffering from viral or mixed infec-
tion with two major viruses (RV and NoV) and two pathogenic bacteria [Enteroaggregative E. coli (EAEC), and 
Enteropathogenic E. coli (EPEC)]. In addition, we investigated the correlation between gut microbiome alterations 
due to various infections and disease manifestations.
Results
Patient characteristics and study design. A total of 79 fecal samples were analyzed, including 70 stool 
samples from children suffering from AGE [RV (n = 40) and NoV (n = 30); median age of 14 months], and 
nine samples from healthy children [median age of 13.5 months]. Of the 40 RV positive children, 18 children 
had RV-alone infection (Vesikari score ≤10), eight had mixed infection with RV + EAEC (Vesikari score >10), 
nine had RV + EPEC infection (Vesikari score > 10) and five samples had RV + EPEC + EAEC mixed infection 
(Vesikari score > 10). Of the 30 NoV positive samples, 17 had NoV-alone infection (Vesikari score ≤10), eight 
had NoV + EAEC (Vesikari score <10) and five children had NoV + EPEC infection (Vesikari score > 10). We 
did not have NoV + EPEC + EAEC, nor single bacterial infections to include in the analysis. The number of chil-
dren vaccinated with RVV in the NoV group [NoV: 76.5% (13/17), NoV + EAEC: 71.4% (5/7), NoV + EPEC: 80% 
(4/5)] was higher compared to RV group [RV: 61.1% (11/18), RV + EAEC: 62.5% (5/8), RV + EPEC: 60% (6/10) 
and RV + EPEC + EAEC: 40% (2/5)]. Children admitted to pediatric emergency center with AGE were observed 
to have multiple clinical characteristics comprised of fever, prolonged period of diarrhea, vomiting, hospitaliza-
tion and both mild to moderate dehydration. All fecal samples were collected before the administration of any 
medications. Table 1 summarizes the clinical characteristics and conditions of the children enrolled in this study.
Mapping the microbiome community composition and biodiversity in AGE patients and healthy 
controls. We sequenced 16S (V4 region) genes on an Illumina MiSeq. Raw Fastq files were quality-filtered 
and clustered into 97% similarity operational taxonomic units (OTUs) using the mothur software package28. For 
all samples, we obtained 1.488075 × 106 high-quality 16S rRNA sequence reads generated from Miseq Illumina 
platform. The final dataset yielded 8118 OTUs including those bacteria with a count of one. The read range which 
was between 1436 and 3.17 × 104 denotes the size of the sequences aligned for the identified OTUs. High quality 
reads were classified using Greengenes (v. 13_8) as the reference database. We obtained a consensus taxonomy 
for each OTU. We then aggregated OTU abundances into genera, and plotted the relative abundances of the most 
abundant ones with Analysis of variance (ANOVA). We have represented a plot to denote the most abundant 
genera for each cohort (Fig. 1), as well as per each group independently (Supplementary Fig. 1). The results of 
positive correlation between relative abundance and prevalence was calculated by using Spearman’s correlation 
coefficient. We summarized OTU abundances with the Bray-Curtis index and performed a non-metric multidi-
mensional scaling (NMDS) analysis to visualize microbiome similarities28. We used a Permutational analysis of 
variance (PERMANOVA) to test the significance of group differences29. Enteric bacteria in the 79 fecal samples 
were classified into 24 phyla, 154 families, and 273 genera based 16S rRNA sequences and metagenomics anal-
ysis of the selected reads. The complete AGE bacterial communities and the relative abundance for each genus, 
phylum and family level for all children samples are listed in Additional File 1. We categorized samples into two 
cohorts: RV cohort which includes RV, RV + EAEC, RV + EPEC, RV + EAEC + EPEC, and NoV cohort which 
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includes NoV, NoV + EAEC, and NoV + EPEC. The relative abundance of species in each group was compared 
with other groups to determine the relatedness.
In all AGE samples, 273 bacterial genera were detected. Despite this large number of gut microbes, a rela-
tively small collection of genera represented 90% of all bacterial reads in all samples. Distinct bacterial compo-
sition and communities were present between healthy samples as compared with RV and NoV groups, which 
Clinical conditions
RV cohorts NoV cohorts Controls
RV-alone RV + EAEC RV + EPEC RV + EPEC + EAEC NoV-alone NoV + EAEC NoV + EPEC Healthy
Number of children 18 8 9 5 17 8 5 9
Number of males 11 6 7 2 12 5 4 5
Number of females 7 2 2 3 5 3 1 4
Median age of children 
(months) 19 28 29 15 15 9 11 13.5
Age range of children 
(months) (3–72) (11–84) (5–72) (10–24) (4–60) (4–23) (7–108) (11–84)
Diarrhea frequency 
(per day) 6–7 7–8 8–9 6–7 5–6 4–5 6–7 NA
Vomiting frequency 
(per day) 5–6 3–5 5–6 5–6 5–6 6–7 6–7 NA
Max reached fever (°C) 38.5 37.1 39 37.5 39.5 37.1 38.8 NA
Mean duration of 
hospitalization (days) 0–1 0–1 1–2 1–2 1 0–1 0–1 NA
Rotavirus vaccinated 61.1% (11/18) 62.5% (5/8) 60% (6/10) 40% (2/5) 76.5% (13/17) 71.4% (5/7) 80% (4/5) NA
Degree of dehydration Mild: 66.7% Mild: 25% Mild: 44.5% Mild: 60% Mild: 65% Mild: 25% Mild: 60% NA
Moderate: 33.3% Moderate: 75% Moderate: 55.5% Moderate: 40% Moderate: 35% Moderate: 62.5% Moderate: 40% NA
Table 1. Clinical characteristics and conditions of the children enrolled in this study. NA: Not available.
Figure 1. Community clustering and composition of top genera of bacterial species and their overall relative 
abundance in 79 children. All gut microbiota OTU profiles of the patients were aggregated into genera and 
plotted. “Other” under the genus represents lower-abundance taxa. Optimal number of consensus taxonomy 
was obtained for each OTU and 12 most abundant genera were displayed. (A) Clustering and composition of 
top 12 genera in RV cohort in comparison with control group. (B) Clustering and composition of top 12 genera 
in NoV cohort in comparison with control group.
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differed in both diversity and composition [Fig. 1(A,B)]. We identified 12 genera showing significant differences 
of relative abundance in community between RV and NoV infected children. We found a positive correlation 
between relative abundance and prevalence of bacteria in both RV and NoV cohorts. That is, a genus highly 
abundant in one sample was also highly prevalent across all samples of the same group. The twelve most abun-
dant genera in RV infected groups were Bifidobacterium, Streptococcus, Escherichia, Bacteroides, Prevotella, 
Veillonella, Faecalibacterium, Clostridium, Collinsella and unclassified genus of Enterobacteriaceae, Veillonellaceae 
and Lachnospiraceae [Fig. 1(A)]. Specifically, genera (abundance value) which includes Streptococcus (0.124), 
Escherichia (0.107), Prevotella (0.0759) and Veillonella (0.0633) showed the highest prevalence and relative 
abundance, and accounted in average for 77.5% of the bacteria in RV positive samples. In the RV + EAEC 
mixed-infection group, Streptococcus and Escherichia genera were also more prevalent and relatively abundant. 
Both genera declined in the RV + EPEC mixed-infection with a mean relative abundance of 0.25 and 0.37, though 
they were prevalent in all samples. Interestingly, predominant abundance of genera Prevotella and Escherichia was 
observed in RV + EAEC + EPEC mixed infections with a mean relative abundance of 0.75 when present. Relative 
abundance with respect to unclassified genera, Lachnospiraceae and Collinsella, were abundant in RV + EPEC 
and RV + EPEC + EAEC, while less abundant in RV + EAEC [Fig. 1(A)]. The twelve top bacterial genera and 
their overall relative abundance per each group individually are represented in Supplementary Data S1- Fig. 
1. Abundance of specific genera was also noticed in each of RV groups, particularly Oscillospira (0.0141) 
(RV-alone and RV + EAEC), Dialister (0.0256) and Megamonas (0.0385) (RV + EPEC), and Sutterella (0.0122) 
(RV + EAEC + EPEC).
On the other hand, the twelve most abundant genera for NoV cohort were Bifidobacterium, Bacteroides, 
Escherichia, Veillonella, Streptococcus, Faecalibacterium, Clostridium, Ruminococcus, Enterococcus and unclas-
sified genus of Enterobacteriaceae, Veillonellaceae and Lachnospiraceae. Escherichia, Veillonella, Streptococcus, 
Faecalibacterium and an unknown genus belonging to the Lachnospiraceae were highly prevalent across all 
NoV positive samples with an average of 60.8%. [Fig. 1(B)]. NoV + EAEC mixed infections was dominated by 
high levels of Streptococcus, Escherichia and Clostridium genera. Although similar pattern was observed with 
NoV + EPEC mixed infections, it was with lesser abundance. It was also interesting to observe that though 
Enterococcus (0.00575) and Veillonellaceae unclassified (0.0157) were listed among the top genera by overall rel-
ative abundance in NoV cohort, they were found less abundant in NoV + EAEC and NoV + EPEC groups. We 
observed that Collinsella and Prevotella which were among the top 12 genera in RV cohort, were not entitled in 
NoV abundant genera. Similarly, unique genera of Ruminococcus and Enterococcus were observed in NoV cohort, 
but were absent in RV cohort. The twelve top bacterial genera and their overall relative abundance per each group 
including healthy controls and NoV cohort are represented in Supplementary Data S1- Fig. 2. Abundance of spe-
cific genera was also noticed in each NoV groups particularly, Sutterella (0.0170) (NoV-alone and NoV + EAEC), 
Haemophilus (0.0163) (NoV-alone), Oscillospira (0.0377) and Dorea (0.022) (NoV + EPEC). In general, we 
noticed that genus Bifidobacterium was less abundant, but prevalent in all the samples of RV and NoV cohorts. 
On the other hand, genus Bacteroides was dominantly abundant in control samples and reduced significantly in 
RV cohort compared to NoV cohort [Fig. 1(B)].
Richness, diversity and differential abundance of gut microbiota of AGE children. To further 
characterize the inter-individual differences between groups (beta-diversity) at the group level, post-hoc test 
and NMDS were performed. Pairwise differences: post-hoc test of gut microbiome in healthy children and AGE 
infected children is shown in Table 2. NMDS analysis revealed separation and clustering of samples along NMDS1 
axis, whilst species tended to cluster along NMDS2 [Fig. 2(A,B)]. Children with RV infection had significantly 
scattered clustering compared to the controls (r2 = 0.074, p = 0.013, pvalBon = 0.13), with higher significance 
observed in RV + EAEC (r2 = 0.146, p = 0.009, pvalBon = 0.09) and RV + EPEC + EAEC (r2 = 0.179, p = 0.010, 
pvalBon = 0.10) (Fig. 2(A) and Table 2]. However, children with RV + EPEC mixed infections appear to show sig-
nificant clustering with higher p-value (r2 = 0.101, p = 0.045, pvalBon = 0.45) compared to the controls (Table 2 
and Fig. 2). We did not detect obvious significant differences when we compared the diversity of RV alone infected 
children with their mixed infections groups. On the other hand, significance with higher p-value was observed 
between RV + EPEC and RV + EPEC + EAEC (r2 = 0.146, p = 0.043, pvalBon = 0.43) groups. Children with NoV 
infection showed microbe clustering compared to healthy samples with higher p-value (r2 = 0.067, p = 0.049, 
pvalBon = 0.29) but high significance was observed in NoV + EAEC (r2 = 0.165, p = 0.009, pvalBon = 0.054) 
[Fig. 2(B)]. Analysis of variance showed no significant association between NoV + EPEC mixed-infection group 
and controls (r2 = 0.097, p = 0.188, pvalBon = 1.12). Overall, the pairwise differences with the control samples 
indicated that mixed infections with RV cohort had significant associations, specifically RV + EAEC mixed infec-
tion (p < 0.05). On the other hand, only NoV infection and NoV + EAEC groups showed significant (p < 0.05) 
associations. Moreover, no association was observed with NoV + EPEC group (p = 1.88).
Shannon diversity index, reported as entropy scores, were calculated for control group and each infected 
group of children and elucidated in Fig. 3. The entropy score is known to increase as the number of species 
increases as well the distribution of individuals among the species becomes even. All RV infected groups reported 
lower entropy scores compared to the control group. Decrease in scores was more significant (p = 0.0024) in 
the mixed infections with EAEC, especially the RV + EAEC 1.65 (1.6–1.9). On the other hand, entropy scores 
were less divergent in the NoV groups, recoding the following values: NoV-alone 2.4 (2.0–2.7), NoV + EAEC 2.3 
(2.0–2.5), and NoV + EPEC 2.3 (2.0–2.9), [Fig. 3(B)]. In summary, Shannon diversity indices suggested severe 
alteration in childrens’ gut microbiome communities with RV single and mixed-infections with EAEC.
We observed 14 RV (padjusted < 0.05) and 20 NoV (padjusted < 0.01) differentially abundant OTUs, respectively, 
in infected children regardless of the bacterial co-infections [Supplementary Data S1- Fig. 3(A,B)]. Each of 
these OTUs represented 0.025–0.3% of the total abundance in RV cohort, and 0.0001 to 0.2% of the total abun-
dance in NoV cohort. OTUs in RV cohort were associated with diverse range of bacteria including Roseburia, 
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Blautia, Parabacteroides faecis, Fusobacterium, Gemella, Moraxella and Pullicaecorum [Supplementary Data S1- 
Fig. 3(A)]. Only five OTUs were significantly abundant in the RV-alone infected children group (padjusted < 0.05), 
compared with healthy controls, including Melaninogenica, Blautia, Bacteroides, Fusobacterium and Gemella. 
Melaninogenica (0.003–0.015%) and Gemella (0.007 to 0.0015%) were observed in RV + EAEC whereas 
Coprocococus (0.005 to 0.010%), Moraxella (0.001–0.06%) and Gemella (0.002–0.008%) were significantly 
abundant in RV + EPEC group. On the other hand, seven OTUs were differentially abundant in NoV cohort 
including Clostridium Citroniae (0.001–0.015%), Haemophilus parainfluenzae (0.01–0.03%), Alistipes putred-
inis (0.003–0.006%), Anaerostipes caccae (0.002–0.04%), Acinetobacter guillouiae (0.001–0.006%), Clostridiales 
(0.004–0.012), and Trachinotus ovatus (0.01 to 0.03). A comparison between EAEC- and EPEC-infected groups 
showed differential abundance of Streptococcus and Coprococcus in both RV + EAEC and NoV + EAEC children, 
whereas Coprococcus and Melaninogenica were differentially abundant in both RV + EPEC and NoV + EPEC 
[Supplementary Data S1- Fig. 3(B)]. Moreover, it was peculiarly noticed that the number of differential abundant 
pathogenic OTUs were found only with NoV mixed infection compared to RV mixed infected groups.







Control samples RV-Alone 0.08 0.013a 0.13 0.043
Control samples RV + EAEC 0.15 0.009a 0.09 0.09
Control samples RV + EPEC 0.1 0.045b 0.45 0.09
Control samples RV + EPEC + EAEC 0.18 0.010a 0.1 0.05
RV-Alone RV + EAEC 0.05 0.257c 2.57 0.286
RV-Alone RV + EPEC 0.04 0.334c 3.34 0.334
RV-Alone RV + EPEC + EAEC 0.06 0.141c 1.41 0.201
RV + EAEC RV + EPEC 0.1 0.060c 0.6 0.1
RV + EAEC RV + EPEC + EAEC 0.11 0.174c 1.74 0.217
RV + EPEC RV + EPEC + EAEC 0.15 0.043b 0.43 0.107
Control samples NoV-Alone 0.07 0.049b 0.294 0.147
Control samples NoV + EAEC 0.17 0.009a 0.054 0.054
Control samples NoV + EPEC 0.1 0.188c 1.128 0.376
NoV- Alone NoV + EAEC 0.06 0.207c 1.242 0.31
NoV- Alone NoV + EPEC 0.04 0.570c 3.42 0.57
NoV + EAEC NoV + EPEC 0.08 0.556c 3.336 0.667
Table 2. Pairwise differences: post-hoc test of gut microbiome in healthy children and AGE (RV and NoV) 
infected children. RV- rotavirus; EAEC-Enteroaggregative E. coli; EPEC-Enteropathogenic E. coli; NoV- 
norovirus. astatistically highly significant between control samples and AGE infection (p < 0.01); bstatistically 
low significant between control samples and AGE infection (p < 0.05); cstatistically not significant within AGE 
(p > 0.05).
Figure 2. Nonmetric multidimensional scaling (NMDS) ordination of fecal microbiota in AGE infected 
patients. The Bray-Curtis index were performed between all infected children and controls to generate NMDS 
to visualize gut microbiome similarities. Each dot in the figure denotes microbiota profile of a single patient in 
a low-dimensional space. Colored dots denotes groups of patient’s microbiome. The subject’s cluster together 
depending upon their microbiome profiles. (A) NMDS ordination of microbiomes in control samples, RV-
alone, RV + EAEC, RV + EPEC, and RV + EPEC + EAEC. (B) NMDS ordination of microbiomes in control 
samples, NV-alone, NV + EAEC, and NV + EPEC.
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Correlation between microbiome composition and clinical manifestations in RV- and NoV- 
alone infected groups. The correlations of the gut microbiota composition with clinical manifestations 
were evaluated based on Table 1. The abundance of genus Clostridium resulted in increased frequency of diar-
rhea (6 to 7 times/day) and vomiting (6 times/day) in children with RV positive infection. Further, children 
with fever had greater richness in Prevotella compared to other genera. On the other hand, abundance of genus 
Streptococcus was observed to be associated with increase in diarrhea duration (7–8 days) in children with NoV 
positive infection.
RV-alone infected children with an increased frequency of diarrhea exhibited greater abundance of Sulfur 
River 1 (SR1) (50%), Lentisphaerae (50%), Nitrospirae (38%) and Caldiserica (5%), which were absent in NoV- 
alone infected and healthy children (Supplementary Data S1 – Fig. 4). Dominance of phyla Chlorobi was asso-
ciated with moderate dehydration in NoV infected children. Microbial profiles and their correlation in phylum 
level between RV, NoV and healthy pediatric cohorts are shown in Supplementary Data S1 – Fig. 4.
Microbiome composition and clinical manifestations in mixed infections with EAEC. In the 
RV + EAEC mixed infection, children with an onset of AGE symptoms for more than 2 days prior to hospital-
ization exhibited significant abundance and Escherichia, and lesser abundance of Bacteroides. The abundance 
of Bacteroides was even lesser in NoV + EAEC group compared to RV + EAEC group. There was no abun-
dance of specific genera that correlated with degree of dehydration in RV + EAEC group. However, genera 
Escherichia, Streptococcus, Rumella and Clostridium seemed to be specifically correlated with degree of dehy-
dration in NoV + EAEC group. Analysis at the phylum level for viral-EAEC mixed infections did not show any 
significant difference in various microbial diversity indices as was observed in RV- and NoV- infections alone 
(Supplementary Data S1 – Fig. 5).
Microbiome composition and clinical manifestations in mixed infections with EPEC. In 
RV + EPEC mixed-infection group, children with high Streptococcus abundance had adverse condition of vom-
iting and diarrhea, reaching approximately 7–8 times per day. Only children infected with Escherichia were 
admitted and hospitalized for more than a day. Similar to our observation with EAEC mixed infection, and in 
comparison with RV + EPEC infected group, NoV + EPEC mixed-infections resulted in substantial decrease in 
genus Bacteroides as well as Bifidobacterium (Supplementary Data S1 – Fig. 6). Importantly, phyla Chlorobi, 
which was observed absent in RV- alone group, was significantly abundant RV + EPEC mixed infections, but 
absent in NoV + EPEC. Conversely, phyla Rubiaceae richness was observed only in NoV + EPEC, but absent 
in RV + EPEC. Furthermore, phyla Nitrospirae was particularly absent in RV- and NoV- mixed infections 
(Additional File 1).
Microbiome composition and clinical manifestations in RV vaccinated cohort. The number of 
children in RV cohort with one or two doses of vaccine represented about 27% and 34.1%, respectively. The most 
notable difference observed in RVV group with one dose was the abundance of Clostridium (1.05E-1) and E. 
Figure 3. Shannon diversity index of microbiota among healthy controls and infected AGE cohorts. 
(A) Analysis of Shannon diversity index in control samples, RV-alone, RV + EAEC, RV + EPEC, and 
RV + EPEC + EAEC. (B) Analysis of Shannon diversity index in control samples, NV-alone, NV + EAEC, and 
NV + EPEC.
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coli (3.28E-1) compared to two doses vaccination. Microbial composition at phylum level denoted higher levels 
of Firmicutes in both vaccinated and non-vaccinated children. Two doses vaccination in children resulted in 
decrease in Bacteroidetes compared to one dose or non-vaccinated. When comparing total number of bacteria 
genera as a whole, RVV vaccinated children either with one or two doses of vaccine, showed less abundance of 
bacterial genera compared to non-vaccinated children (Supplementary Data S1 - Figs 4–6).
Discussion
Few studies have evaluated the microbiota of children suffering from enteric viral infection26, severe and com-
plicated AGE24, and irritable bowel syndrome with diarrhea (IBS-D)30. In the current study, we investigated the 
interplay between viral-bacterial mixed infections in children hospitalized with AGE by evaluating microbiome 
compositions and clinical outcomes in the studied populations. Our study focused on two major viruses (RV and 
NoV) as well as two major pathogenic E. coli (EAEC and EPEC) that are known to cause AGE in children. The 
number of samples evaluated in this study, especially in the viral infection groups, ensured sufficient statistical 
power in data analysis and interpretation as compared to previously published studies.
We found that both, taxonomical composition and the diversity of gut microbiome, were disrupted or altered 
in children infected with single enteric virus, but the disruption was worsened with mixed viral-bacterial infec-
tions as compared to healthy controls. Moreover, reduction or richness of specific bacterial genera was linked 
to increased frequency of diarrhea, vomiting and fever, longer hospitalization and age, but not related to gender 
of the children (Supplementary Data S1 - Figs 4–6). We observed greater richness in bacterial genera in the RV 
infected group compared to NoV infected group (additional file 1), which is in contrast to recent study done by 
Chen et al. 201724. According to their study, RV infection resulted in decreased microbiota diversity compared 
with NoV infection, which has not been reported previously. This difference might be attributed to the NoV sam-
ples included in their study. They enrolled children with complicated clinical conditions including convulsion, 
necrotizing enterocolitis, severe electrolyte imbalance and malnutrition. In addition, all fecal samples collected 
in that study were at least one week after discontinuation of the antibiotics. This could have severely altered the 
microbiome diversity in NoV infected children. Moreover, although the overall mean severity was higher in RV 
infected children in their study, the number of cases evaluated for the comparison was less [RV (n = 5) and NoV 
(n = 15)]. Additionally, Chen et al. study indicated that some of their children were administered antibiotics prior 
to confirmation of a viral infection, which could have drastically altered the gut microbiome.
In comparison to gut microbiota in healthy controls, our results demonstrated that abundance of taxa 
Clostridiaceae and Streptococcaceae in the RV- and NoV-alone infected children had an adverse effect as measured 
by the increased severity of vomiting and diarrhea. In concordance with our findings, the abundance of these two 
bacteria was previously reported by Kersten et al.,198731 in a study that evaluated pediatric gastroenteritis in pri-
mary care and in hospitalized patients. This suggests that the growth of Clostridiaceae and Streptococcaceae may 
be promoted by disturbances in normal gut microflora, even in the absence of antibiotics use32,33; i.e., induced 
by gastroenteritis. Direct interaction of Clostridiaceae with the epithelial cells results in a cascade of inflam-
matory processes that can contribute to intestinal diseases such as diarrhea and pseudomembranous colitis34. 
Interestingly, the richness of Streptococcaceae was also observed with RV + EAEC infections, but the propor-
tion of its richness declined in both RV + EPEC and RV + EPEC + EAEC mixed infections. Similar observa-
tions were noticed with NoV cohort, where Streptococcaceae richness was observed in mixed infections with 
EAEC compared EPEC. The association of Streptococcaceae with one E. coli type (EAEC) infection but not the 
other (EPEC), regardless of the viral infection, is an interesting observation that requires further assessment. 
Several other studies have also reported the abundance of the above taxa in other diseases including gastric 
mucosa-associated microbiota in dyspeptic patients35, cystic fibrosis36, ulcerative colitis37 and chronic rhinosi-
nusitis (CRS)38. Recently, efforts to engineer the microbiome to cure Clostridioides difficile infections through 
fecal microbiota transplantation (FMT) has evolved39. Being currently in the clinical trial, FMT may elucidate the 
factors that determine species-species interaction in the gut environment39.
With respect to the difference in top genera by overall relative abundance of specific populations, our findings 
indicate that the populations of Prevotella and Ruminococcus were significantly increased in RV cohort com-
pared NoV cohort. However, a recent study by Rodríguez-Díaz et al., 2017, specifically link the abundance of 
Ruminococcus to lower immunoglobulin A titers against both NoV and RV40. The occurrence of these bacteria 
in RV infected patients could also depend on other factors including host’s secretor status and RV genotype, as 
described for RV P type (P[6] and P[8]) variants41. On the other hand, population based studies have shown that 
Prevotella and Ruminococcus possess diagnostic values42, where abundance of Prevotella has been associated with 
rural communities43, non-Western44 and a plant-based diet45. These factors were not evaluated in our study and 
worth investigation in future work.
RVV has been shown to substantially reduce morbidity and mortality among children worldwide. Previous 
studies suggest that the use of RVV reduce emergency department visits and hospitalizations of children with 
rotavirus acute gastroenteritis by 70% to 100%. Interestingly, substantial number of RV infected patients in our 
study had received one (n = 9) or two doses (n = 12) of the RV vaccine. We therefor sought of analyzing the 
effect of vaccine on microbiome composition in the different groups involved in this study. When comparing 
total number of bacteria genera as a whole, AGE-affected RV-vaccinated children either with one or two doses of 
vaccine showed slightly less abundance of bacterial genera compared to non-vaccinated children (Supplementary 
Data S1 - Figs 4–6). One-dose vaccination with RVV correlated with abundance to Clostridium and E. coli, similar 
to what has been reported in a recent study by Harris et al.23. In another study that investigated gut microbiome in 
RVV-responder and non-responders Ghanaian infants, bacteria belonging to the Bacteroidetes phylum, especially 
several bacteria related to species from the Bacteroides and Prevotella genera, were significantly associated with 
a lack of RVV response22,46. None of the above studies, including ours, have looked at the RV genotype causing 
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the infection, which could dramatically influence infection severity and consequently gut microbiome. Dietary 
and nutritional status of infants, history of chronic illness, mixed infections, and other factors could explain the 
discrepancies between the different studies. Although our study is the only one that evaluated mixed-infection 
effect on gut microbiota, the low number of patients in the mixed-infection groups did not enable valid statistical 
comparison between groups regarding vaccine effect.
There was no abundance of specific genera that correlated with degree of dehydration in RV groups. However, 
genera Escherichia, Streptococcus, Rumella and Clostridium seemed to be specifically correlated with degree of 
dehydration in NoV groups (Supplemental Figs 3–4). Diarrhea and vomiting frequencies were worsened with 
EPEC mixed infections with both RV and NoV. This is in agreement with previous studies that reported persis-
tent diarrhea in children with viral-EPEC mixed infections47,48, where EPEC is known to be the most common 
cause of acute diarrhea and may also cause persistent diarrhea in children49. In our study, most of the children 
with EPEC mixed infections were admitted and hospitalized for more than a day. Coinfection with EPEC was 
associated with richness of bacteria Rothia, Leptotrichia, and Haemophilus and poorness of genera Lactobacillus 
and Prevotella in both RV and NoV cohorts.
On the other hand, children infected with RV/NoV-EAEC mixed infections showed an onset of AGE 
symptoms for more than 2–3 days prior to hospitalization and exhibited significant abundance in Escherichia. 
Coinfection with EAEC was associated with richness of bacteria genera Lachnospiraceae, Oscillospira, 
Faecalibacterium and unclassified. Triple infection with RV + EAEC + EPEC was associated with preponderance 
of bacterial genera Collinsella, Roseburia, and Sutterella.
Studies detailing viral-bacterial interplays and their effect on microbiome are limited and contradictory. 
Experimental studies in mice revealed exacerbated disturbance of gut microbiota in viral-bacterial mixed 
infections compared to single RV or NoV infections50. In an earlier study, Hori et al. 1996, reported that rota-
virus causes more severe gastroenteritis than bacteria or parasites in Ghanaian children51. Another study from 
Bangladesh found that mixed RV and E. coli infections were similar in severity to infections with E. coli or RV 
alone52. These results indicate that factors other than the enteric pathogens are responsible for disease manifes-
tations. This partially includes gut microbiome, which is an important player in determining immune response 
to- and pathogenesis of GIT infection. Our study partially answer some of the questions, while many remained 
unanswered. A larger follow up study is needed to unveil the contribution of several others factors such as virus 
genotype, levels of virus replication, mixed infections with other pathogens, genetic makeup of the host and 
others. Expectedly, Bacteroidaceae richness was significantly greater in healthy children as this microflora is 
known to maintain the physiologic conditions of the colon53. On the other hand, reduction of relative numbers 
of Bacteroides was reported in both RV and NoV infections, which was more prominent in the mixed infection 
with EPEC and EAEC. Reduced numbers of Bacteroides have been reported earlier in stools from NoV-infected 
patients, which seems to have been more deteriorated in viral-bacterial mixed infection as the case in our study26. 
Whether this reduction Bacteroides is a consequence of infection, or a predisposition factor that facilitated the 
infection requires further investigations. Of note, certain Bacteroidetes express a form of lipopolysaccharide (LPS) 
that is structurally and functionally different from the LPS expressed on E. coli54. LPS is a strong immunogenic 
stimulator, present in the outer membrane of gram-negative bacteria54. Bacteroidetes LPS has been shown to 
inhibit innate immune signaling and endotoxin tolerance as compared with that of E. coli55. This suggests that 
differences in microbiota-derived LPS may modulate aspects of immune education and play a role in determining 
susceptibility to immune diseases. Alternatively, Bifidobacteriaceae, which act as probiotics, seems to increase 
depending on the severity of the infections. That is, we observed an increase in Bifidobacteriaceae richness in the 
viral-bacterial mixed infections compared to single viral infections (Fig. 1). Studies have proven that the decrease 
in Bifidobacteriaceae impairs the gastroenteritis homeostasis and may result in mucosal inflammation in the GI 
tract. In addition to Lactobacillus, strains belonging to Bifidobacterium, are widely used as probiotic bacteria 
and are included in many functional foods and dietary supplements56,57. These probiotics have been reported to 
suppress diarrhea58, exhibit antimicrobial effect59, prevent inflammatory bowel disease60, and alleviate lactose 
intolerance and postoperative complications61,62. Bifidobacterium and Lactobacilli have been also shown to inhibit 
a wide range of pathogens, including Helicobacter pylori, E. coli, Listeria monocytogenes, Salmonella, and RV63–66. 
Our results suggest that our body has evolved mechanisms to combat GIT disease by promoting probiotic bacte-
ria growth over the aggression of pathogenic ones. Nonetheless, generalizations regarding the potential probiotic 
health benefits should not be made because they tend to be strain specific.
Despite the differences in the age of children of each subgroup, we believe that this difference was not a con-
founder and it did not affect the microbiota composition. Although it has been suggested that the composition of 
bacterial communities evolve towards an adult-like configuration after 1–3 year of age, other studies showed that 
it continues to change until teenage years10. Moreover, having age-matched subgroups is difficult for such studies 
and here we present the first data set of results describing mixed infections effect on microbiome. We therefore 
believe that future studies with larger cohorts should count for age, gender, ethnicity, and other factors.
Conclusion
We evaluated the bacterial composition in viral-bacterial AGE mixed infections in correlation with various clin-
ical severities. Our results revealed that richness of Bifidobacteriaceae, which act as probiotics, increased with 
the severity of the viral-bacterial mixed infections. As expected, significant reduction of relative numbers of 
Bacteroides was characterized in both RV and NoV infection, in which was more prominent in mixed infections 
with pathogenic E. coli. Though EAEC mixed infection resulted in significant microbiota alterations compared to 
virus-alone or virus-EPEC mixed infection, the clinical conditions of the children was worsened with both E. coli 
virotypes. This could be attributed to the type of toxins secreted and mode of pathogenesis exerted by each type. 
However, this study did not look into the virulence factors exerted by each of the E. coli types on the gut micro-
bial community, which mandates further investigations. Further, augmented number of differential abundant 
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pathogenic OTUs was peculiarly noticed only with NoV mixed infection. Certain pathogenic commensal bacte-
ria express carbohydrates indistinguishable from human histo-blood group antigen (HBGA) and NoV particles 
bind to these HBGA-expressing bacteria67. Interaction of NoV particles with HBGA-expressing bacteria further 
enhances infection of the host67,68. Viral-bacterial interplay in the gut environment is a rather complicated process 
that involves multiple factors including host genetic makeup, host diet, host immune status, microbiome compo-
sition in addition to the infectious agents. Results from this study will facilitate further studies on the interaction 
between aforementioned factors.
Methods
Ethical approvals. This study was approved by the institutional review board (IRB) committees at Hamad 
Medical Corporation (HMC) and Qatar University (QU). All samples were collected with informed consent 
signed from the parents/legal guardians under IRB approval from HMC (Approval # 16173/19) and exemption 
from QU (Approval # QU-IRB605-E/16). Samples were collected with information about age, nationality and 
clinical data, such as frequency and duration of vomiting, diarrhea, fever, severity of dehydration, and duration 
of hospitalization. All methods were performed in accordance with the relevant national and international guide-
lines and regulations.
Patient enrollment and sample collection. Samples from viral AGE affected children were collected 
from the Pediatric Emergency Center, Hamad Medical Coorporation, Doha, Qatar. Samples were screened 
for viral infections (group A RV and NoV), and bacterial infections (EPEC and EAEC) using the FilmArray 
Gastrointestinal (GI) Panel kit®, BioFire Diagnostics, United States. We evaluated the severity of gastroenteri-
tis using the Vesikari score system69 with the following definitions: A score of 10–20 indicates severe gastro-
enteritis, 7 ≤ 10 indicate moderate, and <7 indicate mild illness. A total of 70 young children with confirmed 
AGE (RV = 18, RV + EAEC = 8, RV + EPEC = 10, RV + EPEC + EAEC = 5, NoV = 17, NoV + EAEC = 7 and 
NoV + EPEC = 5) along with nine healthy children (negative controls) were enrolled in our study. All the fecal 
specimens were processed with 10% glycerol, and stored at −80 °C for bacteria preservation.
Extraction and amplification of 16S rRNA. Total bacterial DNA was extracted using QIAamp UCP 
Pathogen Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s recommendations by using 
Pathogen Lysis Tubes for efficient lysis of cells of gram negative and gram positive bacteria. Bacterial 16S rRNA 
genes were PCR-amplified with dual-barcoded primers targeting the V4 region, as per the protocol of Kozich et al.29. 
The PCR products were normalized, pooled and quantified before being denatured and spiked with PhiX DNA 
control, Illumina®, Unites States.
Handling contamination. The potential for contamination was addressed by co-sequencing of the DNA 
amplified from specimens, and four template-free controls29. Two positive controls, consisting of cloned SUP05 
DNA, were also included (number of copies = 2*106). Operational Taxonomic Units (OTUs) were considered 
putative contaminants (and were removed) if their mean abundance in controls reached or exceeded 25% of their 
mean abundance in specimens.
Illumina MiSeq sequencing. Amplicons were sequenced with an Illumina MiSeq using the 250-bp 
paired-end kit (v.2), Illumina®, Unites States. The resulted bacterial reads were distributed across the samples, 
to demonstrate uniform coverage and clustered with the mothur software package (v. 1.39.5)70, following the 
recommended procedure71.
Microbiome data analysis. High quality reads were classified using Greengenes (v. 13_8) as the reference 
database. Alpha diversity was estimated with the Shannon index on raw OTU abundance tables after filtering 
out contaminants by using the mothur version of the Bayesian classifier71. Positive correlation between relative 
abundance and prevalence was calculated using Spearman’s correlation coefficient. To estimate beta diversity 
across samples, we excluded OTUs occurring in fewer than 10% of the samples with a count of less than three 
and computed Bray-Curtis indices72. We visualized beta diversity, emphasizing differences across samples, using 
non-metric multidimensional scaling (NMDS) ordination. Pairwise differences: post-hoc test was estimated 
to characterize the inter-individual differences between groups (beta-diversity) at the group level. Variation in 
community structure was assessed with permutational multivariate analyses of variance (PERMANOVA) with 
treatment group as the main fixed factor and using 4,999 permutations for significance testing. All analyses were 
conducted in the R environment. To determine which OTUs were driving the differences in microbial compo-
sition, we analyzed negative binomial Generalized Linear Models on each OTU with the DESeq. 2 R package (v. 
1.19.1)73. Hypothesis testing was achieved with likelihood ratio tests. P-values were adjusted using the Bonferroni 
correction (p-values threshold = 0.05) and Benjamini-Hochberg procedure74.
Data Availability
All the necessary data and materials are included in as supporting data and additional files.
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